ClinicalTrials.gov
public full text
Public Domain
Proper Dosage of Ketamine in Intravenous Regional Anesthesia
Ketamine added to Lidocaine can increase duration of pain relief following intraveonous regional anesthesia (IVRA). The purpose of this dose response study is to determine the minimum effective dosage of intravenous Ketamine, added to 3 mg/kg of Lidocaine. We anticipate that one dosage will provide us with the proper balance between sufficient anesthesia and minimal side effects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Subanaesthetic Dose of Ketamine on Depth of Anaesthesia Consistency#383652
- Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect?#886347
- Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects#828186
- Safety and Efficacy of Ketamine Intravenous Infusions in the Treatment of Fibromyalgia#879603
- Comparative Study Between the Effect of Diclofanic and Ketorolac in Post Tonsillectomy Pain Management#846361
Record · ID 1059868
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive